Cytotoxic anticancer drugs from medicinal plants

Phytochemistry Research Progress

Volumn , Issue , 2008, Pages 193-208

  Nguyen, Anh Tho ^a   Duez, Pierre ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Biological testing.; Extraction; Isolation; Medicinal plants; Plant chemotherapeutic agents; Structure elucidation

Indexed keywords

EID: 84892302434     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (46)

1. Anderson JE, Goetz GE, McLaughlin JL, Suffness M. A blind comparison of simple bend-top bioassay and human tumor cell cytotoxicities and antitumor prescreens. Phytochem. Anal. 1991 ; 2: 107-11.
2. Attard G, Greystoke A, Kaye S, De Bono J. Update on tubulin-binding agents. Pathol. Biol. 2006; 54(2): 72-84.
3. Balachandran P, Govindarajan R. Cancer-an ayurvedic perspective. Pharmacol. Res. 2005; 51: 19-30.
4. Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 1985; 24(2): 119-24.
5. Cordell GA, Beecher CWW, Pezzuto JM. Can ethnopharmacology contribute to the development of new anticancer drugs? J. Ethnopharmacol. 1991; 32: 117-33.
6. Cordell GA. Changing strategies in natural products chemistry. Phytochemistry 1995; 40(6): 1585-612.
7. Crouch SP, Kozlowski R, Slater KJ, Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J. Immunol. Methods 1993; 160(1): 81-88.
8. Cragg GM, Boyd MR, Cardellina II JH, Newman DJ, Snader KM, Cloud TG. Ethnobotany and drug discovery: the experience of the US National Cancer Institute. In: Ethnobotany and the search for new drugs. Edited by Chadwick DJ, Marsh J. Ciba foundation symposium. Wiley, Chichester, UK 1994; 185: 178-96.
9. Cragg GM, Simon JE, Jato JG, Snader KM. Drug discovery and development at the national cancer institute: Potential for new pharmaceutical crops. In: Potential for new pharmaceutical crops. Edited by J. Janick. ASHS press, Arlington, USA 1996, p. 554-60.
10. Cragg GM. Paclitaxel (Taxol®): A success story with valuable lessons for natural product drug discovery and development. Med. Res. Rev. 1998; 18(5): 315-31.
11. Cragg GM, Newman DJ. Drugs from nature: past achievements, future prospects. In: Ethnomedicine and drug discovery. Edited by Iwu MM and Wootton JC. Elsevier science B.V, Amsterdam, The Netherlands 2002, p. 23-37.
12. Decker T, Lohmann-Matthes ML. A quick and simple method for the quatitation of lactate dehydrogenase release in measurements of cellular cytotoxicicty and tumor necrosis factor (TNF) activity. J. Immunol. Methods 1988; 115(1): 61-69.
13. Desbene S, Giorgi-Renault S. Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues. Curr. Med. Chem. Anti-Canc. Agents 2002; 2(1): 71-90.
14. Dewick PM. Tumour inhibitors from plants. In: Pharmacognosy. Edited by Evans WC. Saunders WB, London, UK 2002, p. 394-406.
15. Dewick PM. Medicinal natural products-a biosynthetic approach. John Wiley and Sons Ltd., London, UK 2003, p. 205.
16. Farnsworth NR. Ethnopharmacology and drug development. Ciba foundation symposium 1994; 185: 42-59.
17. Flinn IW, Byrd JC, Bartlett N, Kipps T, Gribben J, Thomas D, Larson RA, Rai K, Petric R, Ramon-Suerez J, Gabrilove J, Grever MR. Flavopridol administered as a 24-hour continuous infusion in chronic lymphocyte leukaemia lacks clinical activity. Leukemia Res. 2005; 29(11): 1253-57.
18. Ferrigni NR, Putnam JE, Anderson JE, Jacobsen LB, Nichols DE, Moore DS, McLaughlin JL. Powell RG, Smith CRJ. J. Nat. Prod. 1982; 45(6): 679-86.
19. Jaracz S, Chen J, Kuznetsova LV, Ojima I. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg. and Med. Chem. 2005; 14: 5043-54.
20. Graham JG, Quinn ML, Fabricant DS, Farnsworth NR. Plants used against cancer-an extension of the work of Jonathan Hartwell. J. Ethopharmacol. 2000; 73: 347-77.
21. Hamburger M, Hostettmann K. Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry 1991; 30(12): 3864-74.
22. Hande KR. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 1998; 34(10): 1514-21.
23. Harmon AD, Weiss U, Silverton JV. The structure of rohitukine, the main alkaloid of Amoora rohituka (syn. Aphanamixis polystachya) (Maliaceae). Tetrahydron 1979; 8: 721-24.
24. Harwell JL. Plants used against cancer. Quarterman, Lawrence, USA 1982.
25. Hostettmann K, Wolfender JL, Marston. Hyphenated HPLC techniques for screening and quality control. Society for medicinal plant research: 50 years 1953-2003, a jubilee edition. Wissenschaftliche Verlagsgesellschaft. Stuugart, Germany 2003. p. 99-108.
26. Institute of Medica Materia (IMM). Medicinal plants from Vietnam. Hanoi: Science and Technique press 1990, p. 107.
27. Iwu MM. Introduction: therapeutic agents from ethnomedicine. In: Ethnomedicine and drug discovery. Edited by Iwu MM and Wootton JC. Amsterdam, Elsevier 2002, p. 1-22.
28. Kim J, Park EJ. Cytotoxic anticancer candidates from natural products. Curr. Med. Chem-Anticancer agents 2002; 2: 485-537.
29. Kim JC, Saha D, Cao Q, Choy H. Enhancement of radiation effects by combined docetaxel and flavopiridol treatment in lung cancer cells. Radiother. oncol. 2004; 71: 213-21.
30. Korzeniewski C, Callewaert DM. An enzyme release assay for natural cytotoxicity. J. Immuol. Methods 1983; 64(3): 313-20.
31. Loud WD, Farnsworth NR, Soejarto DD, Quinn ML. NAPRALERT: Computer-handling of natural products research data. J. Chem. Inf. Comput. Sci. 1985; 25(2): 99-103.
32. Mans DRA, Rocha AB, Schwartsmann G. Anti-cancer drug discovery and development in Brazil: Targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. The oncologists 2000; 5: 185-98.
33. Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL. Brine shrimp: A convenient general bioassay for active plant constituents. Planta Med. 1982; 45(1): 31-34.
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 1983; 65(1): 55-63.
35. Mukherjee AK, Basu S, Sarkar N, Ghosh AC. Advances in cancer therapy with plant based natural products. Curr. Med. Chem. 2001; 8: 1467-86.
36. Nachlas MM, Margulies SI, Goldberg JD, Seligman AM. The determination of lactic dehydrogenase with tetrazolium salts. Anal. Biochem. 1960; 1: 317-26.
37. Naik RG, Kattige SL, Bhat SV, Alreja B, De Sousa NJ, Rupp RH. An anti-inflammatory cum immunomodulatory piperidinylbenzopyranone from Dysoxylum binectariferum: isolation, structure and total synthesis. Tetrahedron 1988; 44(7): 2081-86.
38. Newman DJ, Cragg GM, Snader KM. The influence of natural products upon drug discovery. Nat. Prod. Rep. 2000; 17: 215-34.
39. Pettit GR. Marine animal and terrestrial plant anticancer constituents. Pure Appl. Chem. 1994; 66(10/11): 2271-81.
40. Pezzuto JM. Plant-derived anticancer agents. Biochem. Pharmacol. 1997; 53: 121-33.
41. Povlsen CO. Heterotransplants of human tumors in nude mice. Antibiot. Chemother 1980; 28: 15-20.
42. Sedlacek HH. Mechanism of action of flavopiridol. Crit. Rev. Oncol./Hematol. 2001; 38: 139-70.
43. Vlietinck AJ. The future of phytochemistry in the new millennium. In: 2000 years of natural products research past, present and future. Edited by Luijendijk TJC. Phytoconsult 2000, p. 215-22.
44. Wadler S, Schwartz EL. New advanced in interferon therapy of cancer. The oncologist 1997; 2: 254-67.
45. Wang HK. Plant-derived anticancer agents currently in clinical use or in clinical trials. IDrugs 1998; 1(1) 92-102.
46. Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assay. Int. J. Pharm. 2005; 288(2): 369-76.